How should I use this medicine?

The recommended dosage is 45 mg administered subcutaneously once monthly.

Administration Protocol

WAINUA is supplied as a 45 mg/0.8 mL solution in a single-dose autoinjector. Injections should be administered into the abdomen, upper thigh, or back of the upper arm (if administered by a healthcare provider or caregiver). Patients must allow the autoinjector to warm to room temperature for 30 minutes pre-injection and inspect for particulate matter or discoloration. Missed doses should be administered promptly, with subsequent doses resumed monthly. Dose adjustments are unnecessary for mild-to-moderate renal/hepatic impairment, but severe impairment populations were not studied.

Wainua(Eplontersen)
Adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis).
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved